Evidence map›Paper›PMID 41132507›Full record

ReviewExtracellular vesicles and circulating nucleic acids2025

Microfluidic devices for on-chip quantification of extracellular vesicles and associated biomarkers.

Víctor Calero, Carlos Honrado, Alar Ainla, Daniela Macedo, Hugo Silva, Teresa Lage, Sara Abalde-Cela, Lorena Diéguez, María Carmen Blanco-López, Esther Serrano-Pertierra

Abstract readReview
In one paragraph

Review in Extracellular vesicles and circulating nucleic acids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Víctor CaleroDepartment of Applied Physics and Institute of Biotechnology of Asturias, University of Oviedo, Oviedo 33006, Spain.
Carlos HonradoMedical Devices Research Group, International Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.
Alar AinlaMedical Devices Research Group, International Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.
Daniela MacedoMedical Devices Research Group, International Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.
Hugo SilvaMedical Devices Research Group, International Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.
Teresa LageMedical Devices Research Group, International Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.
Sara Abalde-CelaMedical Devices Research Group, International Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.
Lorena DiéguezMedical Devices Research Group, International Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.
María Carmen Blanco-LópezDepartment of Physical and Analytical Chemistry and Institute of Biotechnology of Asturias, University of Oviedo, Oviedo 33006, Spain.
Esther Serrano-PertierraDepartment of Biochemistry and Molecular Biology and Institute of Biotechnology of Asturias, University of Oviedo, Oviedo 33006, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the past decade, extracellular vesicles (EVs) have gained increasing attention in biomedical research. These membrane-bound particles are naturally secreted by cells under both physiological and pathological conditions, and they exhibit a wide range of sizes and molecular compositions. EVs transport bioactive molecules - such as proteins, nucleic acids, and lipids - making them ideal candidates for biomarker discovery. Consequently, their accurate characterization and quantification are critical for understanding their roles in intercellular communication and evaluating their potential in diagnostics, prognostics, disease monitoring, and therapeutic applications. Microfluidic technologies offer promising solutions for EV analysis, addressing key limitations of conventional methods by enabling precise and sensitive measurements with small sample volumes. While microfluidic devices have been predominantly used for EV separation and isolation, their application in EV quantification remains underexplored. Compared to traditional techniques like nanoparticle tracking analysis or flow cytometry, microfluidic systems can provide faster, more accessible alternatives for EV quantification. This review summarizes recent advances in microfluidic technologies for EV quantification, discussing their advantages, current limitations, and future prospects.

Indexed as

Extracellular vesiclesintegrated sensinglab-on-a-chipmicrofluidicsmolecular biomarkerson-chip quantification

Identifiers

PMID41132507
PMCPMC12540263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.